Results 141 to 150 of about 5,562 (221)

Delphi study to elicit expert consensus around decision-making in the treatment of Friedreich ataxia. [PDF]

open access: yesFront Neurol
Kuo SH   +9 more
europepmc   +1 more source

Alpha-lipoic acid supplementation improves pathological alterations in cellular models of Friedreich ataxia. [PDF]

open access: yesOrphanet J Rare Dis
Talaverón-Rey M   +12 more
europepmc   +1 more source

Correction: Mitochondrial impairment, decreased Sirtuin activity and protein acetylation in dorsal root ganglia in Friedreich ataxia models. [PDF]

open access: yesCell Mol Life Sci
Sanz-Alcázar A   +7 more
europepmc   +1 more source

Advancing new therapies for Friedreich ataxia heart disease

open access: yes
Dr Jarmon Lees2023-12-15T00:00:00Research InstitutesFriedreich ataxia is a devastating genetic disorder and heart disease is the leading cause of premature death in patients. There is currently no treatment for Friedreich ataxia heart disease.

core  

Impact of age on neurofilament light chain in Friedreich ataxia: a 1-year longitudinal study. [PDF]

open access: yesBrain Commun
Petrillo S   +9 more
europepmc   +1 more source

Clinical and cognitive assessment in Friedreich ataxia clinical trials: a review. [PDF]

open access: yesFront Neurol
Darriba Á   +4 more
europepmc   +1 more source

Positron emission tomography reveals increased myocardial glucose uptake in a subset of Friedreich ataxia patients. [PDF]

open access: yesSci Rep
Payne RM   +7 more
europepmc   +1 more source

Neuroimaging Biomarkers for Friedreich Ataxia: A Cross-Sectional Analysis of the TRACK-FA Study. [PDF]

open access: yesAnn Neurol
Georgiou-Karistianis N   +33 more
europepmc   +1 more source

Exploring neuropsychiatric symptoms in Friedreich ataxia. [PDF]

open access: yesSci Rep
Karamazovova S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy